Medical Devices - Hearing Healthcare & Diagnostics
Strategic Profile
Demant is the only company in the world that covers all areas of hearing healthcare, from hearing devices and hearing implants to diagnostic instruments and professional hearing care. The acquisition of KIND Group significantly enlarges Demant's Hearing Care footprint, particularly in Germany where the company expects to become the number-one player, enhancing Demant's retail network, scale and customer access.
Cyborg Score Rationale
Management guides to organic growth of 3–6% and EBIT before special items of DKK 4.1–4.5 billion for 2026. However, profitability is under pressure from a weaker hearing-aid market, mix and FX headwinds, and higher leverage. Strategic positioning is strengthened by acquisitions and product innovation, but near-term margin recovery requires successful cost execution.
Top Insights
The launch of Oticon Zeal in October 2025 has been a notable commercial success, receiving very positive user and channel feedback and lifting sales in the first four European markets.
KIND Group acquisition closed in December 2025 with KIND projected to contribute around DKK 300 million to EBIT before special items in 2026.
Demant is rolling out a company-wide cost program expected to deliver around DKK 250 million of EBIT improvement in 2026 and roughly DKK 500 million in annualized savings from 2028 onwards.
The company signed an agreement to divest Oticon Medical, with closing expected by end of Q1 2026, marking a full exit from the Implant Business Area.
Named Competitors
Sonova — Global hearing healthcare company competing in hearing aids and diagnostics
Recent Developments
(December 2025) Completed acquisition of KIND Group, Germany's largest hearing aid retailer, for €700 million
(October 2025) Launched Oticon Zeal flagship hearing aid with strong early commercial success across European markets
(February 2026) Announced 2026 financial targets with 3-6% organic growth and DKK 250M cost savings program
(Q4 2025) Achieved 4% organic growth in second half of year with sequential recovery across all business areas
Open the full interactive Demant A/S report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.